I Teos Therapeutics
Biotechnology, 321 Arsenal 3 St Fl BLDG 312 Ste 301, Cambridge, Massachusetts, 02472, United States, 51-200 Employees
Who is ITEOS THERAPEUTICS
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeut...
Read More
-
Headquarters: 321 Arsenal 3 St Fl BLDG 312 Ste 301, Cambridge, Massachusetts, 02472, United States
-
Date Founded: 2011
-
Employees: 51-200
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ITEOS THERAPEUTICS
iTeos Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ITeos Therapeutics
Answer: iTeos Therapeutics's headquarters are located at 321 Arsenal 3 St Fl BLDG 312 Ste 301, Cambridge, Massachusetts, 02472, United States
Answer: iTeos Therapeutics's official website is https://iteostherapeutics.com
Answer: iTeos Therapeutics's revenue is $250 Million to $500 Million
Answer: iTeos Therapeutics's SIC: 2834
Answer: iTeos Therapeutics's NAICS: 325412
Answer: iTeos Therapeutics has 51-200 employees
Answer: iTeos Therapeutics is in Biotechnology
Answer: iTeos Therapeutics contact info: Phone number: Website: https://iteostherapeutics.com
Answer: iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Companys innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT:CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month